Clinical Trial Update: Low Dose Niacin (Vitamin B3) for Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial evaluating low-dose niacin (vitamin B3) for Parkinson's disease was terminated, and its results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Niacin (Vitamin B3) (niacin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Parkinson's Disease | NA | Status: TERMINATED | Results posted: 2025-03-04